Speaker Details

Mark D. Kaufmann, MD, FAAD

Mark D. Kaufmann, MD, FAAD

BIOGRAPHY

Dr. Mark Kaufmann is a Former President of the American Academy of Dermatology (AAD) and is a Board Certified dermatologist. He is also a Clinical Professor in the Department of Dermatology at Mount Sinai Hospital in New York, and a Voluntary Associate Professor in the Department of Dermatology at the University of Miami Miller School of Medicine. Dr. Kaufmann was in private practice for 25 years in New York City until 2020. Currently he is the Chief Medical Officer of Advanced Dermatology and Cosmetic Surgery managing 160 clinics and research sites across the United States. Dr. Kaufmann currently serves on the Board of Directors of the American Society for Dermatologic Surgery, and the Florida Academy of Dermatology.

SESSIONS

D001 Derm Tank
Jul 17, 2026 4:00 PM - 5:30 PM

DISCLOSURES

Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Advisory Board(Fees); CryoCaptures LLC – Stockholder Private Company(Stock); Dermsquared – Stockholder Private Company(Stock); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Genius Clinic, Inc – Stockholder Private Company(Stock Options); Incyte – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); NuVida – Advisory Board(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Peerwise Medical Corp – Stockholder Private Company(Stock); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); SciBASE – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Xtresse – Stockholder Private Company(Stock);